Top Story
Hurdles Ahead for “Cures” Legislation
Despite overwhelming House approval last month of the “21^st Century Cures” Act, bipartisan support may fall apart in the coming months as key provisions face opposition in the Senate, negotiations begin on reauthorizing FDA drug user fees, and the presidential campaign shifts the debate to broader health issues
...Read more

Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
Contact your sales rep for more information and to secure your sponsorship.

Legal
Biosimilars Litigation: Lessons So Far
The case of Amgen v. Sandoz signals that preliminary injunctions will play a major role in future patent disputes, write Mindy Ehrenfried and William Raich.
...Read more

Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
Contact your sales rep for more information and to secure your sponsorship.

Comment
Boeing, Going, Gone: The End of Group Health Insurance
Come the fall, Boeing employees in St. Louis and South Carolina will get a new coverage alternatives in addition to their Blue Cross and Blue Shield plans. Stephen Littlejohn looks at the implications for health insurers
...Read more

On the road to integration
Moving your multichannel program into the fast lane
On Demand
Join Peter Lammers and Liz Murray from Quintiles as they present insightful research findings regarding the state of the pharmaceutical industry and the use of multi-channel marketing strategies. Learn what other industries apply successfully and get different options for you to actually “make it happen” for your product.
Register for free

Pricing
Dawn of the Age of Value Pricing in Cancer?
With the American Society of Clinical Oncology (ASCO) considering cost data in addition to clinical data when determining the value of cancer treatments, Ram Subramanian outlines six key points every pharma and biotech manufacturer needs to know
...Read more

Partnership
Tufts to Plug China Knowledge Gap with New Partnership
The Tufts Center for the Study of Drug Development aims to plug the knowledge gap at the lower end of China's trade business through a partnership with Shanghai's Fudan University
...Read more

Emerging Pharma Leaders
Pharm Exec's Emerging Pharma Leaders 2015
The 2015 Emerging Pharma Leaders continue to strongly evoke the qualities of “the change generation” while exhibiting greater diversity in leader backgrounds and the skills required to advance to the “c-suite”
...Read more

//Ohr Pharmaceutical, Inc. (New York, NY) announced the promotion of Jason S. Slakter, MD, to Chief Executive Officer. //Galleon Pharmaceuticals (Horsham, PA) announced that Joseph Oliveto will step in as Chief Executive Officer, effective immediately, replacing James Mannion, who is to retire but who will continue to act as a strategic advisor. //Jianqing Bennett was appointed President of Carestream’s (Rochester, NY) Digital Medical Solutions business unit. //Histogenics Corporation (Waltham, MA) promoted Stephen Kennedy to Chief Technology Officer. //